Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations.
about
Heroin-associated nephropathyRelationship between hepatitis B virus infection and chronic kidney disease in Asian populations: a meta-analysis.Membranous nephropathy: from models to manAcute renal failure associated with nonfulminant hepatitis A virus infection.Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathySurvival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.HBV serum and renal biopsy markers are associated with the clinicopathological characteristics of HBV-associated nephropathySerological markers of viral, syphilitic and toxoplasmic infection in children and teenagers with nephrotic syndrome: case series from Mato Grosso State, BrazilHepatitis B virus-related glomerulonephritis: not a predominant cause of proteinuria in korean patients with chronic hepatitis B.Cryoglobulins are not essentialCirculating HBsAg/IgG complexes in idiopathic chronic glomerulonephritisEstablishing the link between hepatitis B virus infection and colorectal adenomaRole of hepatitis B virus infection in pathogenesis of IgA nephropathyThe relationship between HBV serum markers and the clinicopathological characteristics of hepatitis B virus-associated glomerulonephritis (HBV-GN) in the northeastern chinese population.Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including Lamivudine-resistant strains.Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C.HIV-associated immune complex kidney disease.A case of fever and unexplained acute renal failureDecrease of serum Angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B virus infection and negative correlations between the enzyme levels and estimated glumerular filtration rates.Defective antigen presentation by monocytes in ESRD patients not responding to hepatitis B vaccination: impaired HBsAg internalization and expression of ICAM-1 and HLA-DR/Ia molecules.Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation.Lesson from an intriguing case of cryoglobulinemia.Systemic abnormalities in liver disease.Primary Epstein-Barr virus infection and recurrent type I membranoproliferative glomerulonephritis after renal transplantation.Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities.Relationship between occult hepatitis B virus infection and chronic kidney disease in a Chinese population-based cohort.Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy.Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults.Renal Impairment in Chronic Hepatitis B: A Review.
P2860
Q22306016-B6F2DC1F-6920-479B-8EA4-EFB5728460B3Q30244353-12111D2F-A197-4B1A-9852-360D7CEE8DEAQ33872569-67D8F178-0388-4E6B-A572-549341F318FAQ34581111-BE0273EC-8EE4-49E5-9A10-BBEE259F7A9EQ34605442-871AA862-DBF2-4163-A443-5099B50D7939Q34684679-8B08F6C3-7166-41D5-BE6D-C023FF7831C7Q34733451-EABF121E-FD3A-4AE0-96C7-8A0F5B36AD08Q34977267-AE8460D4-C414-4F1F-8037-4FAA3773F273Q35144067-5CB27A38-A3A0-479B-8662-0B72ED831B4AQ35547463-6EF2D803-E458-4354-BB87-A181ECA155EAQ35948713-B057C6DC-0410-47E9-932D-81B0AFB90671Q36062572-69094ECD-4C01-4E24-8C05-26E89EBC4F23Q36309213-32DA2B54-57BC-4658-B27C-FB649555E074Q36403073-2688F4BB-E347-4F2B-9EA6-363AB99A804CQ36485751-AF5AE819-C3FF-4DB6-B6DE-207F93A5A017Q37551343-C2AD98C5-EA9C-4865-A7DC-CD34372808AEQ38702034-9F588767-3DA6-4FC9-8C84-4C2A992B4BC4Q40423391-F3BEF47F-F78C-4AFC-A063-4EADF44F80AAQ41967380-6E3BCDF4-6BAA-41A3-B681-91D65CC1BED8Q42100437-A09ECEB0-AFC8-416E-82B3-706D113B9C92Q42264106-C7F4B300-0504-40F3-9915-03967054DB3AQ42566872-98034FFA-4F3D-465B-9284-5BA74A2E0EE5Q42623529-121AE510-BB71-4CDE-8959-01AEC638C9E7Q45741405-27DF29F9-28EB-4371-8DBB-3E4C79478460Q45744111-E2232D0D-F56A-486A-9147-2FADBC5FB4DFQ52386061-102FC15E-D036-434F-85C3-1ECD1ED5812DQ52915030-CF9401AD-14ED-4D7B-AA8B-4BD5BE18138FQ54940587-8C238920-DFB0-4B72-88EF-A28F99BD5ECDQ55422411-B68F221A-2741-4DFD-AF9B-A57154FFF03DQ55423881-EAEF1F73-4049-45CD-A7D1-F99290EE3F90
P2860
Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B infection and rena ...... nd therapeutic considerations.
@en
Hepatitis B infection and rena ...... nd therapeutic considerations.
@nl
type
label
Hepatitis B infection and rena ...... nd therapeutic considerations.
@en
Hepatitis B infection and rena ...... nd therapeutic considerations.
@nl
prefLabel
Hepatitis B infection and rena ...... nd therapeutic considerations.
@en
Hepatitis B infection and rena ...... nd therapeutic considerations.
@nl
P356
P1433
P1476
Hepatitis B infection and rena ...... nd therapeutic considerations.
@en
P2093
P2888
P304
P356
10.1038/KI.1990.32
P407
P577
1990-02-01T00:00:00Z